Literature DB >> 36034061

Fixed Drug Eruption: An Underrecognized Cutaneous Manifestation of a Drug Reaction in the Primary Care Setting.

George Shaker1, Teja Mehendale2, Charles De La Rosa1.   

Abstract

Fixed drug eruptions (FDEs) are dermatological manifestations of drug reactions that often occur in the same location upon re-exposure to a drug. They usually appear as erythematous-violaceous, circular patches, but several different variants have been described. They can often present without any associated symptoms, but in some cases, patients may complain of pain and pruritus. The lesions are often underdiagnosed or mistaken for insect bites, urticaria, or erythema multiforme; thus, an effort to bring awareness to this condition is warranted. We present a 33-year-old African-American female who presented to the urgent care presenting with several violaceous patches of varying sizes that started two days ago. The lesions were located on the left shoulder, abdomen, right flank region, and behind the right knee. The lesions were associated with mild pain and pruritus. She believed she was bit by insects but denied seeing any insects at home or participating in any recent outdoor activities. She stated that she had a similar rash in the exact locations five months ago. Upon survey of new medications, she stated that she recently started taking her medications again, which include: hydrochlorothiazide, semaglutide, vitamin D supplement, and ibuprofen. Examination of the skin revealed several black, non-blanching macules with a surrounding ring of erythema on the left shoulder (3 x 3cm), abdomen (4 x 3cm), right popliteal region (3 x 2cm), and right flank region (6 x 7 cm). She was prescribed a medium-dose topical steroid cream to apply to the skin twice a day to decrease the intensity of the inflammatory reaction and thus relieve her symptoms. She was also educated on FDEs and was advised to discontinue Ibuprofen, one of the most commonly implicated drugs in FDEs. Upon returning for a follow-up four weeks later, she noted that she discontinued Ibuprofen, and her cutaneous reactions had fully resolved. This case illustrates the prompt and accurate diagnosis of FDE leading to discontinuation of the offending drug and resolution of symptoms. It also represents the essential questions to ask when suspecting FDE.
Copyright © 2022, Shaker et al.

Entities:  

Keywords:  cutaneous adverse drug reaction; dermatological manifestaion; dermatology case report; drug-reaction; fixed drug eruption

Year:  2022        PMID: 36034061      PMCID: PMC9397151          DOI: 10.7759/cureus.28299

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  10 in total

Review 1.  Fixed drug eruptions: presentation, diagnosis, and management.

Authors:  Hal Flowers; Robert Brodell; Melissa Brents; Julie Porter Wyatt
Journal:  South Med J       Date:  2014-11       Impact factor: 0.954

2.  Genetic susceptibility to fixed drug eruption: evidence for a link with HLA-B22.

Authors:  R Pellicano; G Ciavarella; M Lomuto; G Di Giorgio
Journal:  J Am Acad Dermatol       Date:  1994-01       Impact factor: 11.527

3.  Bullous fixed drug eruption masquerading as recurrent Stevens Johnson syndrome.

Authors:  Farid M Dharamsi; Michael D Michener; Jennifer Warner Dharamsi
Journal:  J Emerg Med       Date:  2014-11-27       Impact factor: 1.484

4.  Fixed drug eruptions in children: a series of 23 cases with provocative tests.

Authors:  A J Kanwar; S C Bharija; M S Belhaj
Journal:  Dermatologica       Date:  1986

5.  IFN-gamma-producing effector CD8+ T cells and IL-10-producing regulatory CD4+ T cells in fixed drug eruption.

Authors:  Yuichi Teraki; Tetsuo Shiohara
Journal:  J Allergy Clin Immunol       Date:  2003-09       Impact factor: 10.793

6.  Hyperpigmentation From Fixed Drug Eruption Successfully Treated With a Low-Fluence 1064 nm Nd:YAG Picosecond Laser.

Authors:  Jacqueline Watchmaker; Prasanthi Kandula
Journal:  Dermatol Surg       Date:  2021-11-01       Impact factor: 3.398

Review 7.  Histopathology of drug eruptions - general criteria, common patterns, and differential diagnosis.

Authors:  Wolfgang Weyers; Dieter Metze
Journal:  Dermatol Pract Concept       Date:  2011-01-31

8.  Fixed drug eruption after Pfizer-BioNTech COVID-19 vaccine: A case report.

Authors:  Elodie Lellig; Claudie Mouton-Faivre; Diane Abs; Anne-Claire Bursztejn
Journal:  J Allergy Clin Immunol Pract       Date:  2022-04-22

9.  Fixed drug eruption due to levocetirizine.

Authors:  Ratinder Jhaj; Dinesh Prasad Asati; Deepa Chaudhary
Journal:  J Pharmacol Pharmacother       Date:  2016 Apr-Jun

10.  Fixed-drug Eruptions: What can we Learn from a Case Series?

Authors:  Ratinder Jhaj; Deepa Chaudhary; Dinesh Asati; Balakrishnan Sadasivam
Journal:  Indian J Dermatol       Date:  2018 Jul-Aug       Impact factor: 1.494

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.